| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |